SOURCE: Healthnostics, Inc.

June 24, 2010 12:00 ET

Healthnostics in Final Negotiations for New Acquisition

NEW YORK, NY--(Marketwire - June 24, 2010) -  Healthnostics, Inc. (PINKSHEETS: HNSS), a medical and biotechnology analytics company, disclosed that it is in the final negotiations for a significant stake in our acquisition of a medical manufacturing company, an event that will have an immediate positive impact on earnings. The Company will provide additional details during the coming week.

"Increasing our diversification within the medical field, this is a momentous event in our Company's history because it has the potential to provide a quantum jump in both sales and earnings," said Alan Grofe, President.

About Healthnostics

Healthnostics, Inc. is a medical and biotechnology analytics company that provides comprehensive patient clinical monitoring and risk management systems to acute care hospitals and utilizes its Internet portals to deliver medical and biotechnology resource information to industry professionals as well as to the general public. Healthnostics' major products include: MedGuardian, a patient care monitoring and risk management system for hospitals that is fully Web-based; and through the MedBioWeb subsidiary, MedBioWorld™, one of the largest professional medical and biotechnology directory resource and reference portal sites on the Internet, and FamilyMedicalNet, a companion consumer healthcare information portal.

For further information please visit Healthnostics (, MedBioWorld (, and FamilyMedicalNet (

And visit us on Facebook at

This press release may contain certain statements that are not descriptions of historical information, but are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act of 1934. These forward-looking statements refer to matters that involve risks and uncertainties. Such statements reflect management's current views and are based on certain assumptions. Actual results could differ materially from the assumptions currently anticipated.

Contact Information